Generics

Biocon intros tacrolimus capsules

Biocon's tacrolimus capsules reduces the body’s ability to reject a transplanted organ.
FDA gives nod, tentative OK to Glenmark’s 3 generics

The Mahwah, N.J.-based company has received approval or tentative approval for generics of Otezla, Cialis and Horizant.
FDA clears first generic glucagon for injection kit

Amphastar's generic is a synthetic peptide product that the FDA has deemed to be bioequivalent and thus therapeutically equivalent to Eli Lilly’s Glucagon Emergency Kit for Low Blood Sugar.
ANI launches generic aminocaproic acid

Aminocaproic acid has a market value of approximately $12.7 million, according to IQVIA.
Dr. Reddy’s files application for Reeqonus tablets to treat COVID-19 in Canada

Dr. Reddy’s, alongside Global Response Aid and Appili Therapeutics, has filed an application on behalf of Reeqonus (favipiravir) tablets to treat mild to moderate COVID-19 in adult patients in Canada.
Slayback Pharma obtains FDA nod for generic Taytulla

Slayback Pharma's Merzee is a generic estrogen/progestin combination oral contraceptive.
Camber launches generic Lioresal

Camber's baclofen tablets are available in a dosage strength of 10 mg in 100- and 1000-count bottles, as well as a dosage strength of 20 mg, in 100-, 500- and 1000-count bottles.
Amgen wins FDA OK for biosimilar Rituxan

Amgen's biosimilar Rituxan is expected to be available in January 2021.

Aurobindo acquires Mylan’s clorazepate dipotassium tablets